Accessibility Menu
Smith & Nephew Plc logo

Smith & Nephew Plc(LSE) SN

Current PriceN/A
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1980)+20,137%
5 Year-27%
1 Year-3%
1 Month-2%
Smith & Nephew Plc last closing stock price
MetricPriceDate
Last closeGBX 1,135.002026-07-24
Smith & Nephew Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.39%GBX 1,151.002026-07-17
1 month-1.52%GBX 1,152.502026-06-24
3 month-1.99%GBX 1,158.002026-04-24
Year to date-8.36%GBX 1,238.502025-12-31
1 year-3.12%GBX 1,171.502025-07-24
3 year-4.94%GBX 1,194.002023-07-25
5 year-26.99%GBX 1,554.502021-07-23
Since inception+20,136.89%GBX 0.061980-01-03

Smith & Nephew Plc Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$12.10B

Net Income (TTM)

$1.05B

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 4, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Smith & Nephew Plc

Smith & Nephew plc is a global leader in medical technology, specializing in the development, manufacturing, and marketing of innovative medical devices. The company focuses on orthopaedics, sports medicine, and advanced wound management, providing solutions that enhance patient outcomes and improve healthcare efficiency.

Products and Services
  • Knee and hip implants for joint reconstruction
  • Advanced wound management solutions for chronic and acute wounds
  • Sports medicine products for minimally invasive joint surgeries
Growth Outlook
  • Revenue of $3.31 billion in Q4 2025, reflecting strong demand
  • Net income increased to $342 million in Q4 2025, showcasing profitability
  • Consistent investment in R&D, with $158 million allocated in Q4 2025
Financial Highlights
  • Trailing twelve months (TTM) revenue of $12.1 billion, indicating robust growth
  • Net profit margin of 10.14% TTM, demonstrating effective cost management
  • Dividend yield of 2.55% TTM, appealing for income-focused investors
AI Generated • Jun 30, 2026

Industry

Healthcare Equipment and Supplies

Employees

18,362

CEO

Deepak S Nath, PhD

Headquarters

Watford, HR WD18 8YE, GB

SN Financials

Key Financial Metrics (TTM)

Gross Margin

68.01%

Operating Margin

16.27%

Net Income Margin

10.14%

Return on Equity

11.79%

Return on Capital

11.88%

Return on Assets

6.10%

Earnings Yield

N/A

Dividend Yield

2.59%

Payout Ratio

52.80%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$8.33B

Operating Income

$1.68B

EBITDA

$2.85B

Operating Cash Flow

$2.27B

Capital Expenditure

-$812.10M

Free Cash Flow

$1.45B

Cash & ST Invst.

$557.20M

Total Debt

$3.33B

Smith & Nephew Plc Performance Analysis

Smith & Nephew Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 4,233,709,94611.7%
20232023-12-31USD 4,464,013,3365.4%
20242024-12-31USD 4,546,833,6391.9%
20252025-12-31USD 4,677,172,4352.9%
Smith & Nephew Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-290.4%
Q42024-12-315.5%
Q22025-06-300.2%
Q42025-12-3110.6%
Smith & Nephew Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.21-52.2%
20232023-12-31USD 0.2416.9%
20242024-12-31USD 0.3751.9%
20252025-12-31USD 0.5447.6%
Smith & Nephew Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-29139.9%
Q42024-12-31-8.0%
Q22025-06-3047.8%
Q42025-12-3114.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$3.31B

+17.4%

Gross Profit

$2.17B

+8.8%

Gross Margin

65.65%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

17,349

N/A

Net Income

$342.47M

+276.3%

EBITDA

$885.59M

+62.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$557.20M

+84.5%

Total Debt

$3.33B

+7.9%

Accounts Receivable

$1.43B

+35.0%

Inventory

$2.12B

-11.6%

Long Term Debt

$3.18B

+37.0%

Short Term Debt

$150.00M

-80.4%

Return on Assets

6.10%

N/A

Return on Invested Capital

11.55%

N/A

Free Cash Flow

$589.41M

+150.8%

Operating Cash Flow

$880.25M

+77.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CTEC.LConvaTec Group Plc
£2.16+1.60%
EKF.LEKF Diagnostics Holdings plc
£0.26-1.15%
RUA.LRUA Life Sciences plc
£0.24+4.35%
NCYT.LNovacyt S.A.
£0.38-4.04%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
AALAmerican Airlines Group
$14.48+0.07%

Questions About SN

What is the current price of Smith & Nephew Plc?

Smith & Nephew Plc is trading at N/A per share.

What is the 52-week range for Smith & Nephew Plc?

Over the past 52 weeks, Smith & Nephew Plc has traded between N/A and N/A.

How much debt does Smith & Nephew Plc have?

As of the most recent reporting period, Smith & Nephew Plc reported total debt of $2.47B.

How much cash does Smith & Nephew Plc have on hand?

Smith & Nephew Plc reported $414.11M in cash and cash equivalents in its most recent financial results.

What is Smith & Nephew Plc’s dividend yield?

Smith & Nephew Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.